Acarix
0,569 SEK +5,96 %Vær den første som følger denne virksomhed
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary heart disease. The company's product is a non-invasive test that is put with a note on the patient to analyze sound from the heart. Operations are mainly conducted in the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The head office is located in Malmö.
Omsætning
5,82 mio.
EBIT %
-1.314,09 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
ACARIX
Daglig lav / høj pris
0,543 / 0,57
SEK
Markedsværdi
212,43 mio. SEK
Aktieomsætning
804,42 t SEK
Volumen
1,4 mio.
Finanskalender
Ekstraordinær generalforsamling
09.06.2023
Delårsrapport
24.08.2023
Delårsrapport
09.11.2023
Årsrapport
15.02.2024
Viser Alle indholdstyper